NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹1,448 Cr | ₹1,154 Cr | ₹1,096 Cr | ₹919 Cr | ₹808 Cr |
What is the latest Total Expenditure of NEULAND LABORATORIES ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹1,448 Cr |
| Mar2025 | ₹1,154 Cr |
| Mar2024 | ₹1,096 Cr |
| Mar2023 | ₹919 Cr |
| Mar2022 | ₹808 Cr |
How is Total Expenditure of NEULAND LABORATORIES Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,448 Cr | 25.56 | |
| Mar2025 | ₹1,154 Cr | 5.25 | |
| Mar2024 | ₹1,096 Cr | 19.21 | |
| Mar2023 | ₹919 Cr | 13.72 | |
| Mar2022 | ₹808 Cr | - | |
Compare Total Expenditure of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹24,030.2 Cr | -3.8% | 12.3% | 59.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -3.8% |
12.3% |
59.5% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses